首页> 外国专利> NOVEL 2,4,5-TRISUBTITUTED-1,3-THIAZOLE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARATION, THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE INDUCED BY SPC ACTIVITY CONTAINING 2,4,5- TRISUBSTITUTED-1,3-THIAZOLE DERIVATIVES AS AN EFFECTIVE INGREDIENT

NOVEL 2,4,5-TRISUBTITUTED-1,3-THIAZOLE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARATION, THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE INDUCED BY SPC ACTIVITY CONTAINING 2,4,5- TRISUBSTITUTED-1,3-THIAZOLE DERIVATIVES AS AN EFFECTIVE INGREDIENT

机译:2,4,5-三取代-1,3-噻唑衍生物及其药学上可接受的盐,其制备方法,由包含2,4,5-三取代-1,3-噻唑的SPC活性引起的炎症性疾病的治疗剂有效成分

摘要

Provided are a 2,4,5-trisubstiuted-l,3-thiazole derivative represented by the following Chemical Formula 1, a pharmaceutically acceptable salt thereof, a method for preparation thereof, and a use thereof as an effective ingredient in a therapeutic agent for inflammatory disease induced by sphingosylphosphorylcholine (SPC). The 2,4,5-trisubstiuted-l,3-thiazole derivative of the present invention has been confirmed to have superior inhibition activity against SPC receptor in an animal experiment using human-derived endothelial cells and mice. Thus, a pharmaceutical composition for treating inflammatory disease containing the 2,4,5-trisubstiuted-l,3-thiazole derivative or a pharmaceutically acceptable salt thereof as an effective ingredient may be useful for treating inflammation, itching or skin infection associated with atopic dermatitis or other disease induced by SPC receptor.
机译:提供由以下化学式1表示的2,4,5-三取代的-1,3-噻唑衍生物,其药学上可接受的盐,其制备方法及其在治疗剂中作为有效成分的用途。鞘氨醇磷酸胆碱(SPC)引起的炎症性疾病。在使用人源性内皮细胞和小鼠的动物实验中,已经证实本发明的2,4,5-三取代-1,3-噻唑衍生物具有对SPC受体的优异抑制活性。因此,包含2,4,5-三取代-1,3-噻唑衍生物或其药学上可接受的盐作为有效成分的用于治疗炎症的药物组合物可用于治疗与特应性皮炎相关的炎症,瘙痒或皮肤感染。或SPC受体诱发的其他疾病。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号